TNSN86111A1 - Procede de preparation d'hydroxyalkylxanthines tertiaires - Google Patents

Procede de preparation d'hydroxyalkylxanthines tertiaires

Info

Publication number
TNSN86111A1
TNSN86111A1 TNTNSN86111A TNSN86111A TNSN86111A1 TN SN86111 A1 TNSN86111 A1 TN SN86111A1 TN TNSN86111 A TNTNSN86111 A TN TNSN86111A TN SN86111 A TNSN86111 A TN SN86111A TN SN86111 A1 TNSN86111 A1 TN SN86111A1
Authority
TN
Tunisia
Prior art keywords
preparation
atoms
tertiary
carbon
unustibily
Prior art date
Application number
TNTNSN86111A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of TNSN86111A1 publication Critical patent/TNSN86111A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDE POUR LA PREPARATION DES HYDROXYALKYLXANTHINES TERTIAIRES DE FORMULE GENERALE I DANS LAQUELLE AU MOINS UN DES RADICAUX R1 ET R2 REPRESENTE UN GROUPE HYDROXYALKYLE TERTIAIRE DE FORMULE DANS LAQUELLE R4 REPRESENTE UN GROUPE ALKYLE AYANT JUSQU'À 3 ATOMES DE CARBONE ET N EST UN NOMBRE ENTIER ALLANT DE 2 A 5 . L'AUTRE RADICAL EVENTUELLEMENT PRRESENT R1 OU R2 REPRESENTE UN ATOME D'HYDROGENE OU UN RESTE HYDROCARBONE ALIPHATIQUE R5 AYANT JUSQU'A 6 ATOMES DE CARBONE, DONT LA CHAINE CARBONEE PEUT ETRE INTERROMPUE PAR JUSQU'A 2 ATOMES D'OXYGENE OU ETRE SUBSTITUEE PAR UN GROUPE OXO OU JUSQU'A 2 GROUPES HYDROXY. ET R2 REPRESENTE UN GROUPE ALKYLE AYANT DE 1 A 4 ATOMES DE CARBONE.
TNTNSN86111A 1985-07-19 1986-07-18 Procede de preparation d'hydroxyalkylxanthines tertiaires TNSN86111A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853525801 DE3525801A1 (de) 1985-07-19 1985-07-19 Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung

Publications (1)

Publication Number Publication Date
TNSN86111A1 true TNSN86111A1 (fr) 1990-01-01

Family

ID=6276182

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN86111A TNSN86111A1 (fr) 1985-07-19 1986-07-18 Procede de preparation d'hydroxyalkylxanthines tertiaires

Country Status (33)

Country Link
US (1) US4833146A (fr)
EP (1) EP0268585B1 (fr)
JP (1) JPH0788382B2 (fr)
KR (1) KR950001019B1 (fr)
CN (1) CN1026112C (fr)
AR (1) AR244689A1 (fr)
AT (1) ATE53211T1 (fr)
AU (1) AU588350B2 (fr)
BG (1) BG60767B2 (fr)
CA (1) CA1262248A (fr)
CS (1) CS272766B2 (fr)
DD (1) DD261156A5 (fr)
DE (2) DE3525801A1 (fr)
DK (1) DK157867C (fr)
ES (1) ES2001019A6 (fr)
FI (1) FI89921C (fr)
GR (1) GR861866B (fr)
HU (1) HU198486B (fr)
IE (1) IE59025B1 (fr)
IL (1) IL79457A0 (fr)
LT (1) LT3869B (fr)
LV (1) LV5703A3 (fr)
MA (1) MA20739A1 (fr)
MX (1) MX9254A (fr)
NO (1) NO165803C (fr)
NZ (1) NZ216888A (fr)
OA (1) OA08707A (fr)
PH (1) PH26262A (fr)
PT (1) PT83013B (fr)
RU (1) RU2051918C1 (fr)
TN (1) TNSN86111A1 (fr)
WO (1) WO1987000523A2 (fr)
ZA (1) ZA865374B (fr)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8621870D0 (en) * 1986-09-11 1986-10-15 Beecham Group Plc Active compounds
US5338741A (en) * 1986-10-27 1994-08-16 Nestec S.A. 1-hydroxyalkylxanthines and medicaments containing them
JP2661666B2 (ja) * 1988-02-19 1997-10-08 ヘキスト薬品工業株式会社 抗消化性潰瘍剤
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
DD298051A5 (de) * 1989-08-16 1992-02-06 ��@���������@�������k�� Verfahren zur herstellung eines therapeutischen agens zur behandlung von verdauungskrankheiten
GB8924392D0 (en) * 1989-10-30 1989-12-20 Bayer Ag Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides
EP0430300A3 (en) * 1989-12-01 1992-03-25 Takeda Chemical Industries, Ltd. Xanthine derivatives, their production and use
DE3942872A1 (de) * 1989-12-23 1991-06-27 Hoechst Ag Verfahren zur enantioselektiven darstellung von ((omega)-1)-hydroxyalkylxanthinen
IT1240843B (it) * 1990-05-24 1993-12-17 Malesci Istituto Farmacobiologico Derivati xantinici 1-7 sostituiti ad attivita' antiasmatica, loro sali fisiologicamente accettabili, loro composizioni farmaceutiche e procedimento per la loro preparazione.
DE4019892A1 (de) * 1990-06-22 1992-01-02 Boehringer Ingelheim Kg Neue xanthinderivate
US5039666A (en) * 1990-10-30 1991-08-13 Hoechst-Roussel Pharmaceuticals Inc. Aminoglycoside composition having substantially reduced nephrotoxicity induced by the aminoglycoside
ES2087205T3 (es) * 1990-11-07 1996-07-16 Hoechst Roussel Pharma Uso de xantinas para la preparacion de un medicamento eficaz para inhibir la replicacion de retrovirus humanos.
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
MX9203323A (es) * 1991-07-11 1994-07-29 Hoechst Ag El empleo de derivados de xantina para el tratamiento de lesiones secundarias de las celulas nerviosas y trastornos funcionales despues de traumas craneo-cerebrales.
TW209834B (fr) * 1991-12-11 1993-07-21 Hoechst Ag
ES2096115T3 (es) * 1992-02-22 1997-03-01 Hoechst Ag Uso de derivados de xantina para el tratamiento de lesiones musculares despues de la interrupcion completa de la circulacion sanguinea.
AU669702B2 (en) * 1992-03-04 1996-06-20 Cell Therapeutics, Inc. Enantiomeric hydroxylated xanthine compounds
EP0570831A2 (fr) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Utilisation de dérivés de Xanthine pour le traitement de dommages cérébraux après interruption de la circulation sanguine
US5288721A (en) * 1992-09-22 1994-02-22 Cell Therapeutics, Inc. Substituted epoxyalkyl xanthines
US5817662A (en) * 1992-11-09 1998-10-06 Cell Therapeutics, Inc. Substituted amino alkyl compounds
US5473070A (en) * 1992-11-16 1995-12-05 Cell Therapeutics, Inc. Substituted long chain alcohol xanthine compounds
US6693105B1 (en) 1992-11-16 2004-02-17 Cell Therapeutics, Inc. Hydroxyl-containing compounds
US5804584A (en) * 1992-11-16 1998-09-08 Cell Therapeutics, Inc. Therapeutic compounds containing a monocyclic five- to six- membered ring structure having one to two nitrogen atoms
US5866576A (en) * 1992-12-16 1999-02-02 Cell Therapeutics, Inc. Epoxide-containing compounds
WO1994015605A1 (fr) * 1993-01-14 1994-07-21 Cell Therapeutics, Inc. Composes therapeutiques a substitution acetal ou cetal
AU6092794A (en) * 1993-01-19 1994-08-15 Cell Therapeutics, Inc. Oxime-substituted therapeutic compounds
US5837703A (en) * 1993-03-31 1998-11-17 Cell Therapeutics, Inc. Amino-alcohol substituted cyclic compounds
US5641783A (en) * 1993-11-12 1997-06-24 Cell Therapeutics, Inc. Substituted amino alcohol compounds
US6020337A (en) * 1993-04-05 2000-02-01 Cell Therapeutics, Inc. Electronegative-substituted long chain xanthine compounds
CA2192470A1 (fr) * 1994-01-14 1995-07-20 Paul A. Brown Methode de traitement d'affections dues a la proliferation cellulaire en reponse aux pdgf, egf, fgf et vegf
US6103730A (en) * 1994-03-24 2000-08-15 Cell Therapeutics, Inc. Amine substituted compounds
EP0746557A4 (fr) * 1994-02-18 1997-05-02 Cell Therapeutics Inc Mediateurs de signalisation intracellulaire
US5807861A (en) * 1994-03-24 1998-09-15 Cell Therapeutics, Inc. Amine substituted xanthinyl compounds
US5801182A (en) * 1994-03-24 1998-09-01 Cell Therapeutics, Inc. Amine substituted compounds
DE19540798A1 (de) * 1995-11-02 1997-05-07 Hoechst Ag Alkylxanthinphosphonate und Alkylxanthinphosphinoxide und deren Verwendung als Arzneimittel
US5965555A (en) * 1996-06-07 1999-10-12 Hoechst Aktiengesellschaft Xanthine compounds having terminally animated alkynol side chains
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
DE19707655A1 (de) * 1997-02-26 1998-08-27 Hoechst Ag Kombinationspräparat zur Anwendung bei Demenz
US5985592A (en) * 1997-06-05 1999-11-16 Dalhousie University Uses for pentoxifylline or functional derivatives/metabolites thereof
US6294350B1 (en) 1997-06-05 2001-09-25 Dalhousie University Methods for treating fibroproliferative diseases
US6075029A (en) * 1998-01-02 2000-06-13 Cell Therapeutics, Inc. Xanthine modulators of metabolism of cellular P-450
US20030207901A1 (en) * 1999-07-27 2003-11-06 Cell Therapeutics, Inc. Hydroxyl-containing compounds
DE10042152A1 (de) * 2000-08-26 2002-03-28 Basf Coatings Ag Mit aktinischer Strahlung aktivierbares Thixotropierungsmittel, Verfahren zu seiner Herstellung und seine Verwendung
DE10122390A1 (de) * 2001-05-09 2002-11-28 Basf Coatings Ag Carbamat-und/oder Allophanatgruppen enthaltende, thermisch härtbare, thixotrope Gemische
DE10139262C1 (de) * 2001-08-09 2003-01-02 Basf Coatings Ag Rheologiehilfsmittel, Verfahren zu seiner Herstellung und seine Verwendung
EP1497387A1 (fr) * 2002-04-24 2005-01-19 BASF Coatings Aktiengesellschaft Melanges thixotropes thermodurcissables contenant des groupes carbamate et/ou allophanate
KR100872788B1 (ko) * 2002-05-28 2008-12-09 엘지전자 주식회사 드럼세탁기
US8686090B2 (en) * 2003-12-10 2014-04-01 Basf Coatings Gmbh Use of urea crystals for non-polymeric coatings
US20080081816A1 (en) * 2006-10-03 2008-04-03 Kaohsiung Medical University Anti-inflammation activity of newly synthesized xanthine derivatives kmup-1 and kmup-3
EP2265334A2 (fr) * 2008-02-29 2010-12-29 Concert Pharmaceuticals, Inc. Dérivés de xanthine substitués
AU2009233315B2 (en) * 2008-03-31 2013-08-29 Sun Pharmaceutical Industries Ltd. An improved process for the preparation of morphinane analogues
US8263601B2 (en) 2009-02-27 2012-09-11 Concert Pharmaceuticals, Inc. Deuterium substituted xanthine derivatives
WO2011028820A1 (fr) 2009-09-02 2011-03-10 Concert Pharmaceuticals, Inc. Dérivés substitués de composés [4.3.0] hétéroaryle bicycliques
IN2012DN01642A (fr) 2009-09-02 2015-06-05 Concert Pharmaceuticals Inc
WO2012031072A1 (fr) 2010-09-01 2012-03-08 Concert Pharmaceuticals, Inc. Procédé de préparation d'un alcool secondaire deutéré, enrichi en certains énantiomères, à partir d'une cétone correspondante sans avoir à réduire l'incorporation du deutérium
WO2012031073A1 (fr) 2010-09-01 2012-03-08 Concert Pharmaceuticals, Inc. Procédé de préparation d'un alcool secondaire deutéré à enrichissement énantiomérique à partir d'une cétone correspondante sans réduction de l'intégration de deutérium
CA2869874A1 (fr) 2012-04-13 2013-10-17 Concert Pharmaceuticals, Inc. Derives de xanthine substituee

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1245969B (de) * 1967-08-03 VEB Arzneimittelwerk Dresden, Radebeul Verfahren zur Herstellung von Xanthinderivaten
US2517410A (en) * 1947-08-15 1950-08-01 Searle & Co Hydroxy alkyl xanthines and the production thereof
FR1211333A (fr) * 1955-10-19 1960-03-15 Boehringer Sohn Ingelheim Perfectionnements apportés aux procédés pour fabriquer des oxyalcoylxanthines
DE2335170C2 (de) * 1973-07-11 1989-07-20 Hoechst Ag, 6230 Frankfurt 1,3-Dialkyl-7-(hydroxyalkyl)-xanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US4576947A (en) * 1967-12-16 1986-03-18 Hoechst Aktiengesellschaft Pharmaceutical compositions
BE795345A (fr) * 1972-02-19 1973-08-13 Albert Ag Chem Werke MEDICAMENT UTILE NOTAMMENT POUR L'IRRIGATION CEREBRALE, PROCEDE DE PREPARATION DE SES MATIERES ACTIVES ET CES MATIERES ElLES-MEMES
CH622519A5 (en) * 1974-07-05 1981-04-15 Hoechst Ag Process for the preparation of hydroxyalkylxanthines
DE2432702C2 (de) * 1974-07-08 1983-01-20 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von Hydroxyalkylxanthinen
CA1075690A (fr) * 1974-12-13 1980-04-15 Hoechst Aktiengesellschaft Derives de la xanthine
DE3062499D1 (en) * 1979-04-05 1983-05-05 Beecham Wuelfing Gmbh & Co Kg Dialkoxy- and dioxacycloalkyl-alkyltheobromines, pharmaceutical compositions containing them and their preparation
JPS5838284A (ja) * 1981-09-01 1983-03-05 Teikoku Chem Ind Corp Ltd １−（５′−オキソヘキシル）−３，７−ジメチルキサンチンの製造方法
DE3138397A1 (de) * 1981-09-26 1983-04-07 Hoechst Ag, 6230 Frankfurt "arzneimittel, darin enthaltene vicinale dihydroxyalkylxanthine und herstellungsverfahren fuer diese xanthinverbindungen"
US4575795A (en) * 1983-04-01 1986-03-11 Honeywell Information Systems Inc. Apparatus for detecting a predetermined character of a data string

Also Published As

Publication number Publication date
PT83013A (de) 1986-08-01
IE861917L (en) 1987-01-19
NO165803C (no) 1991-04-10
WO1987000523A3 (fr) 1987-02-26
JPS63501149A (ja) 1988-04-28
PH26262A (en) 1992-04-01
NZ216888A (en) 1989-05-29
AU588350B2 (en) 1989-09-14
CS545386A2 (en) 1990-04-11
ATE53211T1 (de) 1990-06-15
RU2051918C1 (ru) 1996-01-10
DK157867C (da) 1990-07-30
CA1262248A (fr) 1989-10-10
DK139287A (da) 1987-03-18
HUT47274A (en) 1989-02-28
MA20739A1 (fr) 1987-04-01
FI89921B (fi) 1993-08-31
DE3671627D1 (de) 1990-07-05
CS272766B2 (en) 1991-02-12
EP0268585A1 (fr) 1988-06-01
IL79457A0 (en) 1986-10-31
WO1987000523A2 (fr) 1987-01-29
DK157867B (da) 1990-02-26
PT83013B (pt) 1989-01-30
EP0268585B1 (fr) 1990-05-30
KR870700623A (ko) 1987-12-30
CN1026112C (zh) 1994-10-05
FI880174A0 (fi) 1988-01-15
FI89921C (fi) 1993-12-10
AR244689A1 (es) 1993-11-30
BG60767B2 (bg) 1996-02-29
GR861866B (en) 1986-11-17
HU198486B (en) 1989-10-30
NO871111D0 (no) 1987-03-18
LV5703A3 (lv) 1995-02-20
MX9254A (es) 1993-06-01
DE3525801A1 (de) 1987-01-22
LT3869B (en) 1996-04-25
OA08707A (en) 1989-03-31
ES2001019A6 (es) 1988-04-16
FI880174A (fi) 1988-01-15
KR950001019B1 (ko) 1995-02-07
ZA865374B (en) 1987-02-25
LTIP1467A (en) 1995-05-25
US4833146A (en) 1989-05-23
JPH0788382B2 (ja) 1995-09-27
NO165803B (no) 1991-01-02
DD261156A5 (de) 1988-10-19
IE59025B1 (en) 1993-12-15
DK139287D0 (da) 1987-03-18
AU6143986A (en) 1987-02-10
CN86105835A (zh) 1987-01-14
NO871111L (no) 1987-03-18

Similar Documents

Publication Publication Date Title
TNSN86111A1 (fr) Procede de preparation d'hydroxyalkylxanthines tertiaires
ATE73658T1 (de) Diaetzusatz zur verminderung der gefahr einer infektion.
TNSN87033A1 (fr) TOLUNITRILES SUBSTITUES PAR DESα - HETEROCYCLES
ES512381A0 (es) "procedimiento de preparacion de disacaridos".
BE902213A (fr) Composes de phenethanolamine.
BE901958A (fr) Derives de 1-(hydroxymethyl)-1,6,7,11b-tetrahydro-2h, 4h-(1,3)-oxazino - ou - thiazino (4,3,a) isoquinoleine, procede pour leur preparation et compo
FR2412531A1 (fr) Nouveaux 3-(2-hydroxy-4-(substituant)-phenyl)-azacycloalcanones
ATE49957T1 (de) Adamantanamin-derivate, verfahren zur herstellung und diese enthaltende heilmittel.
TNSN86144A1 (fr) Procede pour la preparation de derives de la flavone
FR2452483A1 (fr) Derives d'alcenylphenylmaleimides, leurs dimeres lineaires et leur procede de preparation
BE902060A (fr) Analogues de la morpholinyl-daunorubicine et de la morpholinyl-doxorubicine.
IL91913A0 (en) Fluorosubstituted benzene derivatives,processes for the preparation thereof and diagnostic compositions containing the same
FR2506313A1 (fr) Derives de l'acide n-acetylneuraminique et leur preparation
FR2437206A1 (fr) Composition cosmetique pour les cheveux a base d'un ester glycolipidique hydroxypropyl-etherifie
ES2004141A6 (es) Un procedimiento de preparacion de nuevas 1,4-dihidropiridinas
FR2397425A1 (fr) Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent
DE3371909D1 (en) 7-alpha-acylthio-15,16-methylene-3-oxo-17-alpha-pregna-1,4-diene-21,17-carbolactones, their preparation and use as medicinal agents
FR2411173A1 (fr) Anthranilates de n-hydroxyalkyl-carboxamides et leur application comme reticulants
BE904879A (fr) Alkyl ou aralkyl thio-2 cycloalkene-1 carboxamides-1 et leurs sulfoxydes, leurs procedes de preparation et leur application a la synthese de tri-et tetramethylene-4,5 isothiazoline-4 ones-3.
KR850003658A (ko) N-글리코실화 카르복스아미드 유도체-함유성장-촉진제
FR2498607B1 (fr)
EP0123146A3 (en) Compounds with antiinflammatory activity, process for preparation thereof and pharmaceutical compositions therefrom
DE3481707D1 (de) 7-alpha-substituierte 3-oxo-17alpha-pregn-4-en-21.17-carbolactone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
GB1425729A (en) 1,4-dihydropyridine compounds
FR2362813A1 (fr) Procede de preparation de desoxy-a-acides